comparemela.com

Latest Breaking News On - Olema pharmaceuticals inc - Page 7 : comparemela.com

Olema Pharmaceuticals (NASDAQ:OLMA) Given "Overweight" Rating at Capital One Financial

Olema Pharmaceuticals (NASDAQ:OLMA) Given "Overweight" Rating at Capital One Financial
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

China
Canada
Ohio
United-states
California
G-walmsley-graham
Citigroup
Royal-bank
Olema-pharmaceuticals
News-ratings-for-olema-pharmaceuticals-daily
China-universal-asset-management-co

Capital One Financial Comments on Olema Pharmaceuticals, Inc.'s FY2028 Earnings (NASDAQ:OLMA)

Capital One Financial Comments on Olema Pharmaceuticals, Inc.'s FY2028 Earnings (NASDAQ:OLMA)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Canada
Cyrus-harmon
News-ratings-for-olema-pharmaceuticals-daily
Hedge-funds-weigh-in-on-olema-pharmaceuticals
Citigroup-inc
Virtu-financial
Securities-exchange-commission
Balyasny-asset-management
Olema-pharmaceuticals-company-profile
Nasdaq
Citigroup
Olema-pharmaceuticals-price-performance

ClariVest Asset Management LLC Buys 12,700 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA)

ClariVest Asset Management LLC raised its stake in shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Free Report) by 23.9% in the third quarter, according to its most recent 13F filing with the SEC. The fund owned 65,900 shares of the company’s stock after buying an additional 12,700 shares during the period. ClariVest Asset Management LLC […]

United-states
American
Cyrus-harmon
G-walmsley-graham
American-international-group-inc
Quarter-for-olema-pharmaceuticals
Clarivest-asset-management
Nasdaq
Raymond-james-financial-services-advisors-inc
Olema-pharmaceuticals
Silverarc-capital-management
Olema-pharmaceuticals-inc

vimarsana © 2020. All Rights Reserved.